Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy

Drug Delivery

Ying Zhu¹  Jing Qin²  Jianxin Wang²  Liang Pang³  Wenjie Zhao⁴ 

[1] Insitituteof Clinical Pharmacology, Guangzhou University of Traditional Chinese Medicine, Guangzhou, China;Key Laboratory of Smart Drug Delivery, Ministry of Education & Department of Pharmaceutics, Schoolof Pharmacy, Fudan University, Shanghai, China;Key Laboratory of Smart Drug Delivery, Ministry of Education & Department of Pharmaceutics, Schoolof Pharmacy, Fudan University, Shanghai, China;Shanghai Institute of Pharmaceutical Industry, Shanghai, China;Shanghai Institute of Pharmaceutical Industry, Shanghai, China;

关键词: M1 macrophages;    carrier;    glioma;    nanoparticle;    doxorubicin;   

DOI  :  10.1080/10717544.2018.1502839

来源: publisher

【 摘 要 】

Glioma remains difficult to treat because of the infiltrative growth of tumor cells and their resistance to standard therapy. Despite rapid development of targeted drug delivery system, the current therapeutic efficacy is still challenging. Based on our previous studies, macrophages have been proved to be promising drug carrier for active glioma delivery. To make full use of macrophage carrier, primary M1 macrophages were proposed to replace regular macrophage to deliver nanodrugs into glioma, because M1 macrophages not only have the natural ability to home into tumor tissues, but they also have stronger phagocytic capability than other types of macrophage, which can enable them to uptake enough drug-loaded nanoparticles for therapy. In addition, M1 macrophages are not easily affected by harsh tumor microenvironment and inhibit tumor growth themselves. In this study, M1 macrophage-loaded nanoparticles (M1-NPs) were prepared by incubating poly(lactide-co-glycolide) (PLGA) nanoparticles with primary M1 macrophages. In vitro cell assays demonstrated M1 macrophage still maintained good tumor tropism capability after particle loading, and could efficiently carry particles across endothelial barrier into tumor tissues. In vivo imaging verified that M1-NPs exhibited higher brain tumor distribution than free nanoparticles. DOX@M1-NPs (doxorubicin-loaded M1-NPs) presented significantly enhanced anti-glioma effect with prolonged survival median and increased cell apoptosis. In conclusion, the results provided a new strategy exploiting M1 macrophage as carrier for drug delivery, which improved targeting efficiency and therapeutic efficacy of chemodrugs for glioma therapy.

【 授权许可】

CC BY